Halozyme Therapeutics (HALO) Q2 2024 Earnings

May 7Confirmed
Q3 2023
Q4 2023
Q1 2024
Q2 2024
0.62
0.69
0.75
0.82

Details

Expected EPS
0.68653
Actual EPS
0.79
Surprise EPS
0.1
Surprise Percent
+15.07%

Description

⁨Halozyme Therapeutics⁩ (⁦HALO⁩) has reported earnings of ⁦0.79⁩ per share for ⁦Q2 2024⁩.

0 Comments

Share your thoughts